ARTICLE | Clinical News
Inhaled flecainide: Phase I started
September 5, 2016 7:00 AM UTC
InCarda began a double-blind, placebo-controlled, Australian Phase I trial to evaluate single ascending doses of inhaled flecainide in 38 healthy volunteers. ...